A detailed history of Core Cap Advisors, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Core Cap Advisors, LLC holds 77 shares of WST stock, worth $25,543. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77
Holding current value
$25,543
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$277.16 - $333.3 $21,341 - $25,664
77 New
77 $23,000
Q1 2024

Aug 08, 2024

BUY
$338.27 - $413.0 $18,943 - $23,128
56 New
56 $22,000
Q4 2022

Feb 10, 2023

BUY
$209.34 - $261.61 $50,032 - $62,524
239 New
239 $56,000
Q2 2022

Aug 11, 2022

BUY
$280.61 - $420.45 $79,412 - $118,987
283 New
283 $86,000
Q1 2022

Apr 29, 2022

SELL
$357.49 - $445.92 $487,973 - $608,680
-1,365 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$402.25 - $471.34 $549,071 - $643,379
1,365 New
1,365 $640,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.6B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.